SBC Medical Group (NASDAQ:SBC – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Friday.
SBC Medical Group Stock Up 2.0%
SBC opened at $4.15 on Friday. The company has a market cap of $431.10 million, a PE ratio of 12.97 and a beta of 1.27. SBC Medical Group has a twelve month low of $2.62 and a twelve month high of $12.50. The company has a 50-day moving average price of $4.52 and a 200 day moving average price of $4.14. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03.
SBC Medical Group (NASDAQ:SBC – Get Free Report) last posted its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.12). The firm had revenue of $43.36 million for the quarter, compared to analysts’ expectations of $44.71 million. SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%. Sell-side analysts expect that SBC Medical Group will post 5.02 earnings per share for the current fiscal year.
Hedge Funds Weigh In On SBC Medical Group
About SBC Medical Group
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
- Five stocks we like better than SBC Medical Group
- Transportation Stocks Investing
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- How to Invest in Blue Chip Stocks
- Lululemon Share Price Has Plenty of Room Left to Fall
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.